Previous Article | Next Article 
Journal of Virology, November 2000, p. 10165-10175, Vol. 74, No. 21
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Recombinant Rinderpest Vaccines Expressing
Membrane-Anchored Proteins as Genetic Markers: Evidence of Exclusion of
Marker Protein from the Virus Envelope
Edmund P.
Walsh,
Michael D.
Baron,
Louise F.
Rennie,
Paul
Monaghan,
John
Anderson, and
Thomas
Barrett*
Institute for Animal Health, Pirbright
Laboratory, Pirbright, Surrey GU24 0NF, United Kingdom
Received 28 December 1999/Accepted 10 July 2000
Rinderpest virus (RPV) causes a severe disease of cattle resulting
in serious economic losses in parts of the developing world. Effective
control and elimination of this disease require a genetically marked
rinderpest vaccine that allows serological differentiation between
animals that have been vaccinated against rinderpest and those which
have recovered from natural infection. We have constructed two modified
cDNA clones of the vaccine strain RNA genome of the virus, with the
coding sequence of either a receptor site mutant form of the influenza
virus hemagglutinin (HA) gene or a membrane-anchored form of the green
fluorescent protein (GFP) gene (ANC-GFP), inserted as a potential
genetic marker. Infectious recombinant virus was rescued in cell
culture from both constructs. The RPVINS-HA and RPVANC-GFP viruses were
designed to express either the HA or ANC-GFP protein on the surface of
virus-infected cells with the aim of stimulating a strong humoral
antibody response to the marker protein. In vitro studies showed that
the marker proteins were expressed on the surface of virus-infected
cells, although to different extents, but neither was incorporated into
the envelope of the virus particles. RPVINS-HA- or
RPVANC-GFP-vaccinated cattle produced normal levels of humoral anti-RPV
antibodies and significant levels of anti-HA or anti-GFP antibodies,
respectively. Both viruses were effective in stimulating protective
immunity against RPV and antibody responses to the marker protein in
all animals when tested in a cattle vaccination trial.
*
Corresponding author. Mailing address: Institute for
Animal Health, Pirbright Laboratory, Ash Road, Pirbright, Woking,
Surrey GU24 0NF, United Kingdom. Phone: 44 1483 232 441, ext. 1068. Fax: 44 1483 232 448. E-mail:
tom.barrett{at}bbsrc.ac.uk.
Journal of Virology, November 2000, p. 10165-10175, Vol. 74, No. 21
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Fang, Y., Christopher-Hennings, J., Brown, E., Liu, H., Chen, Z., Lawson, S. R., Breen, R., Clement, T., Gao, X., Bao, J., Knudsen, D., Daly, R., Nelson, E.
(2008). Development of genetic markers in the non-structural protein 2 region of a US type 1 porcine reproductive and respiratory syndrome virus: implications for future recombinant marker vaccine development. J. Gen. Virol.
89: 3086-3096
[Abstract]
[Full Text]
-
Parida, S., Mahapatra, M., Kumar, S., Das, S. C., Baron, M. D., Anderson, J., Barrett, T.
(2007). Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine. J. Gen. Virol.
88: 2019-2027
[Abstract]
[Full Text]
-
Veits, J., Wiesner, D., Fuchs, W., Hoffmann, B., Granzow, H., Starick, E., Mundt, E., Schirrmeier, H., Mebatsion, T., Mettenleiter, T. C., Romer-Oberdorfer, A.
(2006). Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc. Natl. Acad. Sci. USA
103: 8197-8202
[Abstract]
[Full Text]
-
Brown, D. D., Rima, B. K., Allen, I. V., Baron, M. D., Banyard, A. C., Barrett, T., Duprex, W. P.
(2005). Rational Attenuation of a Morbillivirus by Modulating the Activity of the RNA-Dependent RNA Polymerase. J. Virol.
79: 14330-14338
[Abstract]
[Full Text]
-
Baron, M. D.
(2005). Wild-type Rinderpest virus uses SLAM (CD150) as its receptor. J. Gen. Virol.
86: 1753-1757
[Abstract]
[Full Text]
-
Maeda, Y., Hatta, M., Takada, A., Watanabe, T., Goto, H., Neumann, G., Kawaoka, Y.
(2005). Live Bivalent Vaccine for Parainfluenza and Influenza Virus Infections. J. Virol.
79: 6674-6679
[Abstract]
[Full Text]
-
Sola, I., Alonso, S., Zuniga, S., Balasch, M., Plana-Duran, J., Enjuanes, L.
(2003). Engineering the Transmissible Gastroenteritis Virus Genome as an Expression Vector Inducing Lactogenic Immunity. J. Virol.
77: 4357-4369
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Nakaya, T., Cros, J., Park, M.-S., Nakaya, Y., Zheng, H., Sagrera, A., Villar, E., Garcia-Sastre, A., Palese, P.
(2001). Recombinant Newcastle Disease Virus as a Vaccine Vector. J. Virol.
75: 11868-11873
[Abstract]
[Full Text]
-
Stope, M. B., Karger, A., Schmidt, U., Buchholz, U. J.
(2001). Chimeric Bovine Respiratory Syncytial Virus with Attachment and Fusion Glycoproteins Replaced by Bovine Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase and Fusion Proteins. J. Virol.
75: 9367-9377
[Abstract]
[Full Text]